The Journal of Biotechnology (J. Biotech.) offers publication for both full-length articles and short communications on a wide range of biotechnology-related topics. Also, review articles can be submitted if they are pre-approved by one of the editors. The journal will only accept submissions with novel scientific research results that are directly relevant to biotechnological systems and/or applications (for details, please see the list below). J. Biotech. has strict rules about plagiarism. Any submission that includes parts of already published material will be rejected. This includes any attempt to re-publish already published Materials and Methods paragraphs. The journal features a "one-pass review process," i.e., eligible submissions will be reviewed, and those that need improvements (either minor or major) can be resubmitted only once before the decision about whether to accept or reject is decided by the Chief Editor. All figures need to be submitted as high-resolution files during the initial submission. All articles must be written in English, and the quality of the English language will be one of the criteria during the review process.Main Scope of the Journal:Bioprocess engineeringSystem biology, synthetic microbiologyMetabolic engineering, microbial physiologyBiorefinery, biomass engineeringBiochemical enzyme/protein engineeringMetabolic engineeringMicrobial expression systemsBiocatalyst engineeringInsect cell-based modelsMultienzyme cascade reactionsPlant-based biotechnologyOutside of the Scope:Manuscripts lacking noveltyReview articles submitted without previous invitation/confirmation by an editorEnvironmental-related subjects, e.g., waste-water treatment, bioremediation, biodegradationReports on the cloning and/or expression of naturally occurring enzymes without direct biotechnological applicationResearch on natural products without biotechnological modificationToxicological researchPharmacological researchFood science-related research without biotechnological applicationEngineering articles that do not deal with the direct improvement of biotechnological processesGenome research, especially genome sequencing reportsBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Molecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2022 impact factor is 12.4.Visit the Cell Press website for more information about Molecular Therapy - http://www.cell.com/molecular-therapy-family/home
